Legal Representation
Attorney
Bethany J. Whelan
USPTO Deadlines
Next Deadline
2002 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250715)
Due Date
July 15, 2031
Grace Period Ends
January 15, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
43 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 15, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 15, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 16, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jun 25, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jun 24, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 24, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 24, 2025 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| May 6, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| May 6, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| May 6, 2025 | CNFR | W | SU - FINAL REFUSAL - WRITTEN | Loading... |
| Mar 14, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 8, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 8, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 8, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 8, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 4, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 29, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 29, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 29, 2024 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Jul 1, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| May 23, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jul 1, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 23, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Apr 9, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 13, 2024 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED | Loading... |
| Feb 12, 2024 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Jan 25, 2024 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| Jan 11, 2024 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Aug 10, 2023 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Jul 18, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 18, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 28, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 9, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 9, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 9, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 9, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 9, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 5, 2023 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| May 30, 2023 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| May 15, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 15, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 22, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 6, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists administered only by nasal spray; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose administered only by nasal spray; Intranasal drug delivery devices, injector devices for nasal delivery, or devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose
First Use Anywhere:
May 7, 2024
First Use in Commerce:
Aug 7, 2024
Classification
International Classes
005